The global perfusion systems market expected to see steady growth in the coming years, as reported by Transparency Market Research (TMR). The market’s business landscape is abuzz with stiff rivalry among the existing, leading market players.
Key strategies being adopted by vendors in the market is the launch of innovative product line. Several vendors are involved in partnerships and collaborations in order to penetrate the market competition successfully. Several vendors are expected to invest heavily into research and development. Surge in clinical trials of products is expected to bode well for the growth of vendors in the global perfusion systems market in the coming years
Leading vendors in the global perfusion systems market are Medtronic PLC, Samsung Electronics Co, Ltd., General Electricals Inc., Shimadzu Corporation, and Hitachi Ltd.
Thermoplastic Polyurethane Films to Reach US$515.9 Mn by 2024
According to TMR analysts, the global perfusion systems market is expected to rise at a CAGR of 3.4% CAGR over the forecast period 2017 and 2022. In 2017, a revenue valuation of US$0.9 bn had been achieved by the market. By 2022, the market is expected to reach US$1.1 bn.
Based on product, cardiopulmonary perfusion systems is likely to hold a dominant share the market holding 54.8% of the overall demand.
Geographically, North America is expected to emerge as a leading market in the global perfusion systems market. The market is estimated to reach US$0.4 bn by the end of the forecast period.
Launch of Novel Products to Bolster Growth
Expanding number of endorsements and dispatches of novel perfusion systems is expected to be central point impacting development of the perfusion system market in not so distant future. The presentation of mechanically advanced items with the end goal of improved proficiency and cost-adequacy is expected to serve this market with worthwhile chances. For example, presentation of versatile organ perfusion systems is attempted to pick up prominence over the coming years inferable from related advantages with its utilization, for instance its cost-productivity, and portability.
Recently, the U.S. Nourishment and Drugs Administration introduced Xvivo Perfusion AB’s Xvivo Perfusion System (XPS) with STEEN system, utilized in saving at first unsatisfactory contributor lungs while they are being assessed as conceivably feasible transplantable organs.
Steep Cost May Hamper Demand
Staggering expense of perfusion systems is predicted to be a key factor limiting development of the worldwide perfusion system market. For example, as indicated by the information distributed by National Institute for Health and Care Excellence in 2016, cost of the single-use Organ Care System (OCS) Heart Perfusion Set is around US$ 36,904.8, which is a steep expense for emerging economies India, China, and Africa.
In any case, the presentation of warm blood perfusion innovation is expected to offer this industry with future growth avenues.
This review is based on TMR’s report titled, “Perfusion Systems Market (Product Type – Cardiopulmonary, Cell, and EX Vivo Organ; End User – Hospitals, Ambulatory Surgical Centers, and Clinics) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022.”Top of Form
Global Perfusion Systems Market: Product
- Cardiopulmonary Perfusion Systems
- Cell Perfusion Systems
- Ex Vivo Organ Perfusion
Global Perfusion Systems Market: End User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Global Perfusion Systems Market: Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Nordic
- Japan
- Asia Pacific Excluding Japan (APEJ)
- China
- India
- Malaysia
- Thailand
- Singapore
- Australia
- Middle East and Africa (MEA)
- Nigeria
- Israel
- GCC Countries
- South Africa